41. 巨細胞性動脈炎 Giant cell arteritis Clinical trials / Disease details

臨床試験数 : 131 / 薬物数 : 139 - (DrugBank : 36) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 125

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04474847 (ClinicalTrials.gov)	March 15, 2021	13/7/2020	Abatacept for the Treatment of Giant Cell Arteritis	A Randomized Double-Blind, Placebo Controlled Trial of Abatacept(CTLA4-Ig) in Giant Cell Arteritis ( ...	Giant Cell Arteritis	Drug: Abatacept;Drug: Placebo	University of Pennsylvania	NULL	Active, not recruiting	50 Years	N/A	All	78	Phase 3	United States;Canada
2	NCT03192969 (ClinicalTrials.gov)	July 15, 2017	14/6/2017	A Study to Evaluate Efficacy and Safety of Subcutaneous AbataceptWith Steroid Treatment Compared to ...	A Phase III Randomized, Placebo-Controlled, Double-Blind Clinical Trial to Evaluate the Efficacy and ...	Giant Cell Arteritis	Drug: Abatacept;Other: Placebo;Drug: Glucocorticoid Treatment	Bristol-Myers Squibb	NULL	Withdrawn	50 Years	N/A	All	0	Phase 3	United States;Australia;Austria;Belgium;Bulgaria;Canada;Denmark;Estonia;France;Germany;Greece;Irelan ...
3	NCT00556439 (ClinicalTrials.gov)	December 2008	9/11/2007	Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis	Concurrent Pilot Studies in Giant Cell Arteritis and Takayasu's Arteritis to Examine the Safety, Eff ...	Takayasu's Arteritis;Giant Cell Arteritis	Drug: Abatacept;Drug: Placebo	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	The Cleveland Clinic;Office of Rare Diseases (ORD);Rare Diseases Clinical Research Network	Completed	15 Years	N/A	All	97	Phase 2	United States;Canada

First Previous1Next Last